Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical
company focused on developing and commercializing differentiated
products that address patients’ unmet needs and solve therapeutic
problems, today announced that due to the public health and safety
concerns related to the COVID-19 pandemic the location of its
Annual Meeting of Stockholders has been changed to a virtual-only
format, via live audio webcast. Stockholders will not be able
to attend the Annual Meeting in person.
As previously announced, the Annual Meeting will
be held on Tuesday, June 16, 2020 at 9:30 a.m., Eastern Time.
Online access to the meeting will begin at 9:15 a.m., Eastern
Time.
The Company is modifying the meeting format due
to the COVID-19 pandemic and will determine whether future Annual
Meetings will be hosted in-person or via a virtual format depending
on future health concerns.
At the virtual meeting, stockholders will
generally have the same rights and opportunities to participate as
they would at an in-person meeting, including the right to vote and
to ask questions.
To access the virtual meeting stockholders are
to go to www.meetingcenter.io/236154631. To log in to the
virtual meeting, stockholders will be required to have a 15-digit
control number and the meeting password:
AQST2020. A stockholder who does not have a
control number may log in to the virtual meeting as a guest but
will not have the option to vote or ask questions (see below under
“Attending the Annual Meeting as a Guest”).
Beginning 15 minutes prior to, and during, the
Annual Meeting, stockholders and guests will be able to review the
Company’s Rules of Conduct for the Annual Meeting once logged in to
the virtual meeting.
The Company’s 2019 Annual Report and 2020 Proxy
Statement are available at www.envisionreports.com/AQST or at the
Company’s investor relations website by visiting
investors.aquestive.com and clicking on the SEC Filings page.
Attending the Virtual Meeting as a
Stockholder of Record
If you were a stockholder of record as of April
20, 2020 (i.e., you held your shares in your own name as reflected
in the records of our transfer agent, Computershare), you can
attend the meeting by accessing
www.meetingcenter.io/236154631 and entering the 15-digit
control number on the Proxy Card, Email or Notice of Internet
Availability of Proxy Materials previously distributed and the
meeting password: AQST2020.
Registering to Attend the Annual Meeting
as a Beneficial Owner
Beneficial owners as of the record date must
register in advance to attend the virtual Annual Meeting other than
as a guest. If you were a beneficial owner of record as of
April 20, 2020 (i.e., you held your shares in an account at a
brokerage firm, bank or other similar agent), to register, you will
need to obtain a legal proxy from your broker, bank or other agent.
Once you have received a legal proxy from your broker, bank or
other agent, it should be emailed to the Company’s transfer agent,
Computershare, at legalproxy@computershare.com and should be
labeled “Legal Proxy” in the subject line. Please include proof
from your broker, bank or other agent of your legal proxy (e.g., a
forwarded email from your broker, bank or other agent with your
legal proxy attached or an image of your legal proxy attached to
your email). Requests for registration must be received by
Computershare no later than 5:00 p.m., Eastern Time on Thursday,
June 11, 2020. You will then receive a confirmation of your
registration, with a control number, by email from Computershare.
To attend the meeting, go to
www.meetingcenter.io/236154631 and enter your 15-digit control
number and the meeting password: AQST2020.
Obtaining a legal proxy from your broker, bank
or other agent will revoke any prior instructions you gave such
nominee on how to vote shares held on your behalf at the Annual
Meeting. If you request and obtain a legal proxy from your
broker, bank or other agent, you must vote at the virtual Annual
Meeting in order for your vote to be counted.
Asking Questions
If you are attending the meeting as a
stockholder of record or registered beneficial owner, questions can
be submitted during the meeting by accessing the meeting center at
www.meetingcenter.io/236154631, entering your 15-digit control
number and meeting password: AQST2020, and
clicking on the message icon at the top of the page. To return to
the main page, click the “i” icon in the upper left-hand corner of
the page.
After the business portion of the Annual Meeting
concludes and the formal meeting is adjourned, the Company will
hold a general Q&A session during which the Company intends to
answer questions submitted during the meeting that are pertinent to
the Company or to the items before the meeting, as time permits and
in accordance with the Rules of Conduct.
Voting Shares
If you have not already voted your shares in
advance, you will be able to vote your shares electronically during
the Annual Meeting by clicking on the “Cast Your Vote” link on the
meeting center site. Whether or not you plan to attend the Annual
Meeting, stockholders are urged to vote and submit their proxy in
advance of the Annual Meeting by one of the methods described in
the proxy materials for the Annual Meeting previously
distributed.
The Proxy Card and Voting Instruction Form (or
Notice of Internet Availability of Proxy Materials) included with
the previously distributed proxy materials will not be updated to
reflect the change in location and may continue to be used to vote
shares in connection with the Annual Meeting.
List of Stockholders
A list of stockholders of record will be
available during the Annual Meeting for inspection by stockholders
for any legally valid purpose related to the Annual Meeting at
www.meetingcenter.io/236154631.
Attending the Annual Meeting as a
Guest
If you would like to enter the meeting as a
guest in listen-only mode, click on the “I am a guest” button after
entering the meeting center at
www.meetingcenter.io/236154631 and enter the information
requested. Please note you will not have the ability to ask
questions or vote during the meeting if you participate as a
guest.
Technical Support
Online access to the virtual meeting will open
at 9:15 a.m., Eastern Time on Tuesday, June 16, 2020, to allow you
time to log in and test your device’s audio system. The
Company encourages you to access the meeting in advance of the
meeting start time. If you need technical support after you
access the meeting center, click the “Help” link on the upper
right-hand corner of the broadcast screen.
About Aquestive
Therapeutics
Aquestive Therapeutics is a pharmaceutical
company that applies innovative technology to solve therapeutic
problems and improve medicines for patients. Aquestive is advancing
a late-stage proprietary product pipeline to treat CNS conditions
and provide alternatives to invasively administered standard of
care therapies. The Company also collaborates with other
pharmaceutical companies to bring new molecules to market using
proprietary, best-in-class technologies, like PharmFilm®, and has
proven capabilities for drug development and commercialization.
PharmFilm® and the Aquestive logo are registered
trademarks of Aquestive Therapeutics, Inc.
Investor Contact:Stephanie
Carringtonstephanie.carrington@westwicke.com646-277-1282
Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Apr 2024 to May 2024
Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From May 2023 to May 2024